Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 3
1986 9
1988 3
1989 4
1990 2
1991 5
1993 4
1994 4
1995 2
1996 2
1997 1
1999 2
2000 3
2001 2
2002 2
2003 2
2004 3
2005 5
2006 1
2008 6
2009 13
2010 8
2011 4
2012 8
2013 10
2014 18
2015 15
2016 5
2017 10
2018 8
2019 4
2020 10
2021 7
2022 3
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M. Fenske W, et al. Among authors: schopohl j. N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760. N Engl J Med. 2018. PMID: 30067922 Free article.
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients.
Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S, Machado MC, Hanzu FA, Zopp S, Ritzel K, Riester A, Braun LT, Kreitschmann-Andermahr I, Storr HL, Bansal P, Barahona MJ, Cosaro E, Dogansen SC, Johnston PC, Santos de Oliveira R, Raftopoulos C, Scaroni C, Valassi E, van der Werff SJA, Schopohl J, Beuschlein F, Reincke M. Rubinstein G, et al. Among authors: schopohl j. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz136. doi: 10.1210/clinem/dgz136. J Clin Endocrinol Metab. 2020. PMID: 31665382 Free article.
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; Pasireotide C2402 Study Group. Gadelha MR, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):875-84. doi: 10.1016/S2213-8587(14)70169-X. Epub 2014 Sep 24. Lancet Diabetes Endocrinol. 2014. PMID: 25260838 Clinical Trial.
Perspectives on investigational drugs for acromegaly.
Störmann S, Schopohl J. Störmann S, et al. Among authors: schopohl j. Expert Opin Investig Drugs. 2016;25(4):381-4. doi: 10.1517/13543784.2016.1142530. Epub 2016 Feb 6. Expert Opin Investig Drugs. 2016. PMID: 26765281 No abstract available.
Emerging drugs for acromegaly.
Störmann S, Schopohl J. Störmann S, et al. Among authors: schopohl j. Expert Opin Emerg Drugs. 2014 Mar;19(1):79-97. doi: 10.1517/14728214.2014.875529. Epub 2013 Dec 28. Expert Opin Emerg Drugs. 2014. PMID: 24400774 Review.
New and emerging drug therapies for Cushing's disease.
Störmann S, Schopohl J. Störmann S, et al. Among authors: schopohl j. Expert Opin Pharmacother. 2018 Aug;19(11):1187-1200. doi: 10.1080/14656566.2018.1504021. Epub 2018 Jul 26. Expert Opin Pharmacother. 2018. PMID: 30048162 Review.
Biochemical Control in Cushing's syndrome: Outcomes of the treatment in a large single center cohort.
Ritzel K, Fazel J, August L, Fedtke V, Nowak E, Vogel F, Braun L, Zopp S, Then C, Künzel H, Reisch N, Zimmermann P, Thorsteinsdottir J, Schopohl J, Bidlingmaier M, Beuschlein F, Reincke M, Rubinstein G. Ritzel K, et al. Among authors: schopohl j. J Clin Endocrinol Metab. 2024 May 20:dgae337. doi: 10.1210/clinem/dgae337. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38767080
Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study.
Zamanipoor Najafabadi AH, van der Meulen M, Priego Zurita AL, Faisal Ahmed S, van Furth WR, Charmandari E, Hiort O, Pereira AM, Dattani M, Vitali D, de Graaf JP, Biermasz NR; MTG6 Pituitary of Endo-ERN. Zamanipoor Najafabadi AH, et al. Endocr Connect. 2022 Dec 13;12(1):e220349. doi: 10.1530/EC-22-0349. Print 2023 Jan 1. Endocr Connect. 2022. PMID: 36327151 Free PMC article. Review.
169 results